J. Monti

发表

Serotonin control of sleep-wake behavior.

J. Monti, Jaime M Monti, 2011, Sleep medicine reviews.

The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking.

J. Monti, H. Jantos, 2008, Progress in brain research.

Are cholinergic, noradrenergic, and serotonergic neurons sufficient for understanding REM sleep control?

J. Monti, 1986, Behavioral and Brain Sciences.

Spontaneous behavior and sleep-wakefulness cycle in isolated and paired REM sleep deprived-marihuana treated rats

J. Monti, E. Carlini, 1975, Pharmacology Biochemistry and Behavior.

Dopamine and Sleep

S. Chokroverty, J. Monti, Seithikurippu R Pandi-Perumal, 2016, Springer International Publishing.

Nicotine Dependence and Its Treatment

C. Heyser, T. Robbins, P. Svenningsson, 2010 .

Pharmacotherapy of Insomnia: Focus on Zolpidem Extended Release

S. Pandi-Perumal, D. Spence, R. Hardeland, 2009 .

A Critical Assessment of the Melatonin Effect on Sleep in Humans

D. Cardinali, J. Monti, 2000, Neurosignals.

Catecholamines and the sleep-wake cycle. I. EEG and behavioral arousal.

J. Monti, 1982, Life sciences.

Effects of the 5-HT7 receptor antagonist SB-269970 microinjected into the dorsal raphe nucleus on REM sleep in the rat

J. Monti, H. Jantos, 2006, Behavioural Brain Research.

EEG dissociation induced by muscarinic receptor antagonists: Coherent 40 Hz oscillations in a background of slow waves and spindles

J. Monti, P. Torterolo, Joaquín González, 2019, Behavioural Brain Research.

Minireview. Catecholamines and the sleep-wake cycle. II. REM sleep.

J. Monti, 1983, Life sciences.

Effects of H1- and H2-histamine receptor agonists and antagonists on sleep and wakefulness in the rat

J. Monti, H. Jantos, T. Pellejero, 2005, Journal of Neural Transmission.

Effects of clozapine on the activity of central dopaminergic and noradrenergic neurons

J. Monti, M. Souto, H. Altier, 1979, Pharmacology Biochemistry and Behavior.

Pharmacotherapy of Insomnia

D. Neubauer, S. Pandi-Perumal, D. Spence, 2018, Journal of central nervous system disease.

Conventional and power spectrum analysis of the effects of zolpidem on sleep EEG in patients with chronic primary insomnia.

D. Monti, J. Monti, F. Alvariño, 2000, Sleep.

Effect of a Reversible Monoamine Oxidase-A Inhibitor (Moclobemide) on Sleep of Depressed Patients

D. Monti, J. Monti, P. Alterwain, 1989, British Journal of Psychiatry.

The histamine H3 receptor and its relation to normal and altered behavior

J. Monti, 2000, European Neuropsychopharmacology.

Association between migraine and restless legs syndrome

D. Spence, J. Monti, A. Bahammam, 2014, Somnologie - Schlafforschung und Schlafmedizin.

Recent and Relevant

E. Nestler, A. Schapira, S. Pandi-Perumal, 2011, Journal of the International Neuropsychological Society.

Effects of L-arginine and SIN-1 on sleep and waking in the rat during both phases of the light-dark cycle.

J. Monti, H. Jantos, 2004, Life sciences.

Narcolepsy or Sleep Apnea?: Not Everything is What it Appears to be!

S. Pandi-Perumal, J. Monti, Ravi Gupta, 2013, Front. Neurol..

EFFECTS OF OXOLINIC ACID ON THE SLEEP‐WAKEFULNESS CYCLE OF THE RAT

J. Monti, L. D'Angelo, 1981, British journal of pharmacology.

Effects of the selective dopamine D-2 receptor agonist, quinpirole on sleep and wakefulness in the rat.

J. Monti, H. Jantos, M. Fernández, 1989, European journal of pharmacology.

Orexin and Sleep

T. Sakurai, J. Monti, Seithikurippu R Pandi-Perumal, 2015, Springer International Publishing.

Pharmacokinetics: basic concepts for dosage regimen considerations

J. Verster, J. Monti, Seithikurippu R Pandi-Perumal, 2008 .

Effects of the 5-HT6 receptor antagonists SB-399885 and RO-4368554 and of the 5-HT2A receptor antagonist EMD 281014 on sleep and wakefulness in the rat during both phases of the light–dark cycle

J. Monti, H. Jantos, 2011, Behavioural Brain Research.

Sleep and Waking during Acute Histamine H3 Agonist BP 2.94 or H3 Antagonist Carboperamide (MR 16155) Administration in Rats

D. Monti, J. Monti, H. Jantos, 1996, Neuropsychopharmacology.

Effects of a-fluoromethylhistidine on sleep and wakefulness in the rat

J. Monti, H. Jantos, L. D'Angelo, 2005, Journal of Neural Transmission.

Sleep variables are unaltered by zolantidine in rats: Are histamine H2-receptors not involved in sleep regulation?

J. Monti, H. Jantos, M. Boussard, 1990, Brain Research Bulletin.

Effects on Sleep of Melanin-Concentrating Hormone (MCH) Microinjections into the Dorsal Raphe Nucleus of the Cat

J. Monti, P. Torterolo, H. Jantos, 2009, Sleep and Vigilance.

THE EFFECTS OF NEUROLEPTICS WITH CENTRAL DOPAMINE AND NORADRENALINE RECEPTOR BLOCKING PROPERTIES IN THE l‐DOPA AND (+)‐ AMPHETAMINE‐INDUCED WAKING EEG IN THE RAT

J. Monti, 1979, British journal of pharmacology.

Hypnoticlike effects of cannabidiol in the rat

J. Monti, 1977, Psychopharmacology.

The functional relationship between septal and hippocampal unit activity and hippocampal theta rhythm.

O. Macadar, R. Budelli, J. Monti, 1970, Physiology & behavior.

EFFECTS OF SELECTIVE ACTIVATION OR BLOCKADE OF THE HISTAMINE H3 RECEPTOR ON SLEEP AND WAKEFULNESS

J. Monti, H. Jantos, M. Boussard, 1991, European journal of pharmacology.

The involvement of dopamine in the modulation of sleep and waking.

D. Monti, J. Monti, Jaime M Monti, 2007, Sleep medicine reviews.

Sleep disturbance in schizophrenia

D. Monti, J. Monti, 2005, International review of psychiatry.

Biphasic effects of dopamine D-2 receptor agonists on sleep and wakefulness in the rat

J. Monti, H. Jantos, M. Hawkins, 2004, Psychopharmacology.

Noradrenergic modulation of REM sleep: pharmacological evidence

J. Monti, 1983 .

Effect of recurrent stimulation of the brain stem reticular formation on REM sleep in cats.

J. Monti, 1970, Experimental neurology.

Dose‐dependent effects of the 5‐HT1A receptor agonist 8‐OH‐DPAT on sleep and wakefulness in the rat

J. Monti, H. Jantos, 1992, Journal of sleep research.

The serotonin 5-HT7 receptor agonist LP-44 microinjected into the dorsal raphe nucleus suppresses REM sleep in the rat

M. Leopoldo, J. Monti, H. Jantos, 2008, Behavioural Brain Research.

The effects of moclobemide on nocturnal sleep of depressed patients.

D. Monti, J. Monti, D. Monti, 1990, Journal of affective disorders.

The effects of local microinjection of selective dopamine D1 and D2 receptor agonists and antagonists into the dorsal raphe nucleus on sleep and wakefulness in the rat

J. Monti, H. Jantos, 2018, Behavioural Brain Research.

Sleep and circadian rhythm dysregulation in schizophrenia

D. Cardinali, S. Pandi-Perumal, D. Spence, 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Clinical Pharmacology of Sleep

S. Pandi-Perumal, J. Monti, S. Pandi‑Perumal, 2006 .

A study of the brain structures involved in the acute effects of fluoxetine on REM sleep in the rat.

J. Monti, H. Jantos, 2005, The international journal of neuropsychopharmacology.

Differential effects of the 5-HT1A receptor agonist flesinoxan given locally or systemically on REM sleep in the rat.

J. Monti, H. Jantos, Jaime M Monti, 2003, European journal of pharmacology.

Melanin-Concentrating Hormone (MCH): Role in REM Sleep and Depression

J. Monti, P. Torterolo, C. Scorza, 2015, Front. Neurosci..

Sleep and nighttime pruritus in children with atopic dermatitis.

D. Monti, J. Monti, R. Vignale, 1989, Sleep.

Involvement of histamine in the control of the waking state.

J. Monti, Jaime M. Monti, 1993, Life sciences.

Disturbances of sleep and wakefulness associated with the use of antihypertensive agents.

J. Monti, 1987, Life sciences.

Ganglionic blocking action of some methylpiperidines.

J. Monti, K. Vidal-Beretervide, R. Ruggia, 1966, The Journal of pharmacology and experimental therapeutics.

Cannabinoids and Neuropsychiatric Disorders

J. Monti, Haidong Dong, Wim E. Crusio, 2021 .

Clinical Management of Sleep and Sleep Disorders With Cannabis and Cannabinoids: Implications to Practicing Psychiatrists

J. Monti, S. Pandi‑Perumal, 2022, Clinical neuropharmacology.

Melanin-Concentrating Hormone and Sleep

J. Monti, P. Torterolo, S. R. Pandi-Perumal, 2018, Springer International Publishing.

Microinjection of melanin-concentrating hormone (MCH) into the median raphe nucleus promotes REM sleep in rats

J. Monti, P. Torterolo, A. Mondino, 2020, Sleep Science.

Microinjection of the dopamine D2-receptor antagonist Raclopride into the medial preoptic area reduces REM sleep in lactating rats

J. Monti, P. Torterolo, Matías Cavelli, 2017, Neuroscience Letters.

The actions of dopaminergic and noradrenergic antagonists on conditioned avoidance responses in intact and 6-hydroxydopamine-treated rats

J. Monti, M. Souto, M. E. Taboada, 1979, Psychopharmacology.

Pharmacology of the histaminergic system

J. Monti, 1995 .

Sleep in schizophrenia patients and the effects of antipsychotic drugs.

D. Monti, J. Monti, 2004, Sleep medicine reviews.

The role of dorsal raphe nucleus serotonergic and non-serotonergic neurons, and of their receptors, in regulating waking and rapid eye movement (REM) sleep.

J. Monti, 2010, Sleep medicine reviews.

The role of serotonin 5-HT7 receptor in regulating sleep and wakefulness

J. Monti, H. Jantos, 2014, Reviews in the neurosciences.

COMBINED EFFECTS OF MIDAZOLAM AND ETHANOL ON SLEEP AND ON PSYCHOMOTOR PERFORMANCE IN NORMAL SUBJECTS

J. Monti, G. Piñeyro, F. Alvariño, 1989, Fundamental & clinical pharmacology.

Sleep in Patients with Schizophrenia or Unipolar or Bipolar Disorder: The Effect of Second-Generation Antipsychotic Drugs

D. Spence, J. Monti, P. Torterolo, 2022, Sleep and Neuropsychiatric Disorders.

The effects of second generation antipsychotic drugs on sleep variables in healthy subjects and patients with schizophrenia.

J. Monti, P. Torterolo, Seithikurippu R. Pandi Perumal, 2017, Sleep medicine reviews.

Sleep in Schizophrenia Patients and the Effects of Second Generation Antipsychotic Drugs

J. Monti, P. Torterolo, S. Perumal, 2016 .

Sleep disturbance in generalized anxiety disorder and its treatment.

D. Monti, J. Monti, 2000, Sleep medicine reviews.

Effect of zolpidem on sleep in insomniac patients

J. Monti, 2004, European Journal of Clinical Pharmacology.

Pharmacological Treatment of Chronic Insomnia

D. Monti, J. Monti, 1995 .

Serotonin and sleep : molecular, functional and clinical aspects

B. Jacobs, D. Nutt, J. Monti, 2008 .

Melanin-Concentrating Hormone in Medical Conditions

Alicia Costa, J. Monti, P. Torterolo, 2018 .

Melanin-Concentrating Hormone: A New Sleep Factor?

J. Monti, P. Torterolo, P. Lagos, 2011, Front. Neur..

Immunoneutralization of melanin-concentrating hormone (MCH) in the dorsal raphe nucleus: Effects on sleep and wakefulness

J. Monti, P. Torterolo, H. Jantos, 2011, Brain Research.

GABA and Sleep

J. Monti, Seithikurippu R Pandi-Perumal, H. Möhler, 2010 .

Functional Interactions Between MCHergic and Dopaminergic Neurons: Role in the Control of Wakefulness and Sleep

J. Monti, P. Torterolo, L. Benedetto, 2016 .

The structure of the dorsal raphe nucleus and its relevance to the regulation of sleep and wakefulness.

J. Monti, 2010, Sleep medicine reviews.

Interactions Between GABAergic and Serotonergic Processes in the Dorsal Raphe Nucleus in the Control of REM Sleep and Wakefulness

J. Monti, 2010 .

Mechanisms involved in the inhibition of REM sleep by serotonin

J. Monti, H. Jantos, 2008 .

Effects of activation and blockade of 5-HT2A/2C receptors in the dorsal raphe nucleus on sleep and waking in the rat

J. Monti, H. Jantos, 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

The incidence of premature contractions in coronary patients during the sleep-awake cycle.

J. Monti, J. Dighiero, L. E. Folle, 1975, Cardiology.

Serotonin 5-HT(2A) receptor antagonists in the treatment of insomnia: present status and future prospects.

J. Monti, Monti Jm, 2010, Drugs of today.

When insomnia is not just insomnia: the deeper correlates of disturbed sleep with reference to DSM-5.

D. Spence, J. Monti, Ravi Gupta, 2014, Asian journal of psychiatry.

Overview of currently available benzodiazepine and nonbenzodiazepine hypnotics

D. Monti, J. Monti, 2006 .

Zolpidem's use for insomnia.

D. Spence, J. Monti, K. Buttoo, 2017, Asian journal of psychiatry.

The effect of second-generation antipsychotic drugs on sleep parameters in patients with unipolar or bipolar disorder.

J. Monti, 2016, Sleep medicine.

Histamine H1 Receptor Antagonists in the Treatment of Insomnia

D. Monti, J. Monti, 2000 .

Clarifying the role of sleep in depression: A narrative review

D. Spence, Gregory M. Brown, J. Monti, 2020, Psychiatry Research.

Effects of accumbens m-chlorophenylbiguanide microinjections on sleep and waking in intact and 6-hydroxydopamine-treated rats.

R. Silveira, J. Monti, H. Jantos, 1999, European journal of pharmacology.

Depletion of brain serotonin by 5,7-DHT: effects on the 8-OH-DPAT-induced changes of sleep and waking in the rat

R. Silveira, J. Monti, H. Jantos, 1994, Psychopharmacology.

Microinjection of melanin concentrating hormone into the lateral preoptic area promotes non-REM sleep in the rat

J. Monti, P. Torterolo, V. D’Almeida, 2013, Peptides.

Neurochemistry and Pharmacology of Sleep

J. Monti, G. Vanini, P. Torterolo, 2019, The Behavioral, Molecular, Pharmacological, and Clinical Basis of the Sleep-Wake Cycle.

Polysomnographic study of the effect of melatonin on sleep in elderly patients with chronic primary insomnia.

D. Cardinali, J. Monti, I. Savio, 1999, Archives of gerontology and geriatrics.

The effects of the combined administration of gamma-hydroxybutyrate and diazepam on sleep parameters in the rat

J. Monti, H. Altier, L. D'Angelo, 2005, Journal of Neural Transmission.

Benzodiazepines and new non-benzodiazepine agents

J. Monti, 2003 .

Increase of waking and reduction of NREM and REM sleep after nitric oxide synthase inhibition: prevention with GABAA or adenosine A1 receptor agonists

D. Monti, J. Monti, H. Jantos, 2001, Behavioural Brain Research.

Evidence of melatonin involvement in pindolol-induced suppression of REM sleep

D. Monti, J. Monti, H. Jantos, 2001, Journal of Neural Transmission.

Selective Serotonin 5-HT2A Receptor Antagonists and Inverse Agonists Specifically Promote Slow Wave Sleep (Stage N3) in Man

D. Spence, J. Monti, P. Torterolo, 2017, Sleep and Vigilance.

General Principle of Treatment of Sleep Dysfunction and Pharmacology of Drugs Used in Sleep Disorders

J. Monti, 2017 .

The Effects of Benzodiazepine and Nonbenzodiazepine Agents, Ramelteon, Low-dose Doxepin, Suvorexant, and Selective Serotonin 5-HT2A Receptor Antagonists and Inverse Agonists on Sleep and Wakefulness

J. Monti, P. Torterolo, S. Pandi‑Perumal, 2016 .

The Pharmacological Treatment of Sleep Disorders

J. Monti, 2015 .

Septal unit activity and hippocampal EEG during the sleep-wakefulness cycle of the rat.

O. Macadar, R. Budelli, J. Monti, 1971, Physiology & behavior.

Chapter 1 Neuroanatomy and Neuropharmacology of Sleep and Wakefulness

J. Monti, P. Torterolo, S. Pandi‑Perumal, 2016 .

Sleep and waking in 5,7-DHT-lesioned or (−)-pindolol-pretreated rats after administration of buspirone, ipsapirone, or gepirone

R. Silveira, J. Monti, H. Jantos, 1995, Pharmacology Biochemistry and Behavior.

The Role of 5-HT2A/2C Receptors in Sleep and Waking

J. Monti, H. Jantos, 2011 .

Sleep and Antipsychotic Drugs in Schizophrenia Patients

D. Monti, J. Monti, 2006 .

Melanin-concentrating hormone control of sleep-wake behavior.

Pablo Torterolo, J. Monti, P. Torterolo, 2013, Sleep medicine reviews.

THE ACTIONS OF DIHYDROXYPHENYLALANINE AND DIHYDROXYPHENYLSERINE ON THE SLEEP‐WAKEFULNESS CYCLE OF THE RAT AFTER PERIPHERAL DECARBOXYLASE INHIBITION

J. Monti, M. Moldes, H. Altier, 1975, British journal of pharmacology.

The Involvement of 5-HT 2A Receptor in the Regulation of Sleep and Wakefulness, and the Potential Therapeutic Use of Selective 5-HT 2A Receptor Antagonists and Inverse Agonists for the Treatment of an Insomnia Disorder

D. Spence, J. Monti, P. Torterolo, 2018 .

The effects of systemic administration and local microinjection into the central nervous system of the selective serotonin 5-HT2C receptor agonist RO-600175 on sleep and wakefulness in the rat

J. Monti, H. Jantos, 2015, Behavioural pharmacology.

Effects of the serotonin 5-HT2A/2C receptor agonist DOI and of the selective 5-HT2A or 5-HT2C receptor antagonists EMD 281014 and SB-243213, respectively, on sleep and waking in the rat.

J. Monti, H. Jantos, Jaime M Monti, 2006, European journal of pharmacology.

Effects of selective activation of the 5-HT1B receptor with CP-94,253 on sleep and wakefulness in the rat

D. Monti, J. Monti, H. Jantos, 1995, Neuropharmacology.

5-HT receptor agonists 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and 8-OH-DPAT increase wakefulness in the rat

J. Monti, G. Piñeyro, H. Jantos, 1990 .

The effects of p-chlorophenylalanine, reserpine, methysergide and cyproheptadine on the dopa-induced EEG synchronization in the rat.

J. Monti, V. Ziman, H. Altier, 1978, European journal of pharmacology.

Role of Orexin on Sleep: Interactions with Other Neurotransmitter Systems

J. Monti, P. Torterolo, S. Pandi‑Perumal, 2015 .

Microinjection of the nitric oxide synthase inhibitor l-NAME into the lateral basal forebrain alters the sleep/wake cycle of the rat

J. Monti, H. Jantos, 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Role of nitric oxide in sleep regulation: effects of l-NAME, an inhibitor of nitric oxide synthase, on sleep in rats

D. Monti, J. Monti, A. Ponzoni, 1999, Behavioural Brain Research.

Effects of the 5-HT1A receptor ligands flesinoxan and WAY 100635 given systemically or microinjected into the laterodorsal tegmental nucleus on REM sleep in the rat

J. Monti, H. Jantos, 2004, Behavioural Brain Research.

Hypocretin (orexin) immunoreactivity in the feline midbrain: Relevance for the generation of wakefulness

Alicia Costa, J. Monti, P. Torterolo, 2020, Journal of Chemical Neuroanatomy.

Activation of the serotonin 5-HT3 receptor in the dorsal raphe nucleus suppresses REM sleep in the rat

J. Monti, H. Jantos, 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Blockade of ovarian compensatory hypertrophy and ovulation in the rat by hypothalamic implants of an anticholinergic drug

J. Monti, M. Sala, W. Benedetti, 2005, Journal of Neuro-Visceral Relations.

Treating insomnia with medications

J. Pagel, J. Monti, S. Pandi‑Perumal, 2018, Sleep Science and Practice.

Role of dorsal raphe nucleus serotonin 5-HT1A receptor in the regulation of REM sleep.

D. Monti, J. Monti, 2000, Life sciences.

Sleep laboratory study of the effects of midazolam in insomniac patients

J. Monti, P. Alterwain, H. Altier, 2004, European Journal of Clinical Pharmacology.

Principles and Practice of Geriatric Sleep Medicine: Treatment of sleep disorders in the elderly

J. Monti, A. Monjan, S. Pandi‑Perumal, 2009 .

Dopaminergic Regulation of Serotonergic Dorsal Raphe Neurons: Role in the Control of Wakefulness and REM Sleep

J. Monti, P. Torterolo, 2021, Sleep and Vigilance.

The effects of selective activation of the 5-HT3 receptor with m-chlorophenylbiguanide on sleep and wakefulness in the rat.

J. Monti, H. Jantos, A. Ponzoni, 1993, European journal of pharmacology.

Effects of the D3 preferring dopamine agonist pramipexole on sleep and waking, locomotor activity and striatal dopamine release in rats

R. Silveira, J. Monti, H. Jantos, 1998, European Neuropsychopharmacology.

Eszopiclone: its use in the treatment of insomnia

J. Monti, S. Pandi-Perumal, 2007, Neuropsychiatric disease and treatment.

Primary and Secondary Insomnia: Prevalence, Causes and Current Therapeutics

J. Monti, Jaime M. Monti, 2004 .

Blockade of the NMDA and AMPA/kainate receptors in the dorsal raphe nucleus prevents the 5-HT3 receptor agonist m-chlorophenylbiguanide-induced suppression of REM sleep in the rat

J. Monti, H. Jantos, Valentina Catenaccio, 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Increased REM sleep after intra-dorsal raphe nucleus injection of flesinoxan or 8-OHDPAT: prevention with WAY 100635

D. Monti, J. Monti, H. Jantos, 2002, European Neuropsychopharmacology.

Dorsal raphe nucleus administration of 5-HT1A receptor agonist and antagonists: effect on rapid eye movement sleep in the rat.

D. Monti, J. Monti, H. Jantos, 2000, Sleep research online : SRO.

Activation of serotonin 5-HT1B receptor in the dorsal raphe nucleus affects REM sleep in the rat

J. Monti, H. Jantos, P. Lagos, 2010, Behavioural Brain Research.

Stereoselective antagonism by the pindolol enantiomers of 8-OH-DPAT-induced changes of sleep and wakefulness

J. Monti, H. Jantos, 1994, Neuropharmacology.

Physiology of Normal Sleep

J. Monti, S. Pandi‑Perumal, Ahmed S. Bahammam, 2022, Sleep and Neuropsychiatric Disorders.

Microinjection of the melanin-concentrating hormone into the sublaterodorsal tegmental nucleus inhibits REM sleep in the rat

J. Monti, P. Torterolo, H. Jantos, 2016, Neuroscience Letters.

Effect of SX-3228, a selective ligand for the BZ1 receptor, on sleep and waking during the light-dark cycle in the rat.

D. Monti, J. Monti, H. Jantos, 1999, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

The effect of chlorpromazine on the adrenal gland in rats with brain stem lesions

J. Monti, E. Balea, R. Domínguez, 1967, Experientia.

Systemic administration and local microinjection into the central nervous system of the 5-HT7 receptor agonist LP-211 modify the sleep-wake cycle in the rat

M. Leopoldo, J. Monti, H. Jantos, 2014, Behavioural Brain Research.

The effects of systemic and local microinjection into the central nervous system of the selective serotonin 5-HT6 receptor agonist WAY-208466 on sleep and wakefulness in the rat

J. Monti, H. Jantos, L. Schechter, 2013, Behavioural Brain Research.

Effects of pretreatment with 6-hydroxydopamine or noradrenergic receptor blockers on the clonidine-induced distruption of conditioned avoidance responding.

J. Monti, M. Hawkins, 1979, European journal of pharmacology.

Sleep laboratory and clinical studies of the effects of triazolam, flunitrazepam and flurazepam in insomniac patients.

J. Monti, 1981, Methods and findings in experimental and clinical pharmacology.

Zolpidem and rebound insomnia--a double-blind, controlled polysomnographic study in chronic insomniac patients.

D. Monti, J. Monti, P. Morselli, 1994, Pharmacopsychiatry.

Selective Serotonin 5-HT2A Receptor Antagonists and Inverse Agonists Specifically Promote Slow Wave Sleep (Stage N3) in Man

D. Spence, J. Monti, P. Torterolo, 2017, Sleep and Vigilance.

The effects of ritanserin on mood and sleep in abstinent alcoholic patients.

J. Monti, P. Alterwain, F. Alvariño, 1993, Sleep.

New directions in the treatment of insomnia

D. Monti, J. Monti, 2005 .

Increased REM sleep after intra-locus coeruleus nucleus microinjection of melanin-concentrating hormone (MCH) in the rat

J. Monti, P. Torterolo, H. Jantos, 2015, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Microinjection of the melanin-concentrating hormone into the lateral basal forebrain increases REM sleep and reduces wakefulness in the rat.

J. Monti, P. Torterolo, H. Jantos, 2012, Life sciences.

Effects on Sleep of Melanin-Concentrating Hormone (MCH) Microinjections into the Dorsal Raphe Nucleus of the Cat

J. Monti, P. Torterolo, P. Lagos, 2021, Sleep and Vigilance.

The Effects of Melanin-Concentrating Hormone on Neurotransmitter Systems Involved in the Generation and Maintenance of Wakefulness

J. Monti, P. Torterolo, S. Pandi‑Perumal, 2018 .

Activation of the serotonin 5-HT3 receptor in the dorsal raphe nucleus suppresses REM sleep in the rat

J. Monti, H. Jantos, 2008, Progress in Neuro-psychopharmacology and Biological Psychiatry.

Sleep and circadian rhythm dysregulation in schizophrenia

D. Cardinali, D. Spence, Gregory M. Brown, 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Microinjection of the 5-HT7 receptor antagonist SB-269970 into the rat brainstem and basal forebrain: Site-dependent effects on REM sleep

M. Leopoldo, J. Monti, H. Jantos, 2012, Pharmacology Biochemistry and Behavior.

Microinjection of melanin concentrating hormone into the lateral preoptic area promotes non-REM sleep in the rat

J. Monti, P. Torterolo, V. D’Almeida, 2013, Peptides.

References References Liberation from Cerebral Cortex during Paradoxical

Aldrich, Jasper, Gaillard, 2012 .

Serotonin and sleep : molecular, functional and clinical aspects

B. Jacobs, D. Nutt, J. Monti, 2008 .

The selective histamine H1-receptor agonist 2-(3-trifluoromethylphenyl)histamine increases waking in the rat

J. Monti, H. Jantos, W. Schunack, 1994, European Neuropsychopharmacology.

Potentiation of the haloperidol-induced blockade of a conditioned avoidance response by alpha-methyltyrosine.

J. Monti, M. Ruiz, 1973, European journal of pharmacology.

Effects of haloperidol, trifluperidol, nitrazepam and chlordiazepoxide upon conditioned midbrain behavioral responses

J. Monti, N. Ross, 2004, Psychopharmacologia.

pO2 recorded in the amygdaloid complex during the sleep-waking cycle of the cat

J. Monti, R. Velluti, 1976, Experimental Neurology.

Increased disrupting effects of haloperidol on a conditioned avoidance response after 6-hydroxydopamine treatment

J. Monti, M. Ruiz, 1975, Pharmacology Biochemistry and Behavior.

Effects of methoxamine and alpha-adrenoceptor antagonists, prazosin and yohimbine, on the sleep-wake cycle of the rat.

J. Monti, H. Jantos, T. Pellejero, 1984, Sleep.

Midazolam and sleep in insomniac patients.

J. Monti, P. Alterwain, L. D'Angelo, 1983, British journal of clinical pharmacology.

Flunitrazepam (Ro 5-4200) and sleep cycle in insomniac patients

J. Monti, F. Morales, H. M. Trenchi, 1974, Psychopharmacologia.

Flunitrazepam (Ro 5-4200) and sleep cycle in normal subjects

J. Monti, H. Altier, 1973, Psychopharmacologia.

Effect of xipamide and furosemide on guinea pig cochlear recorded potentials.

I. Pose, J. Monti, R. Velluti, 1983, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.